India
· Delayed Price · Currency is INR J. B. Chemicals & Pharmaceuticals Company Description
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally.
The company’s API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI.
It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms.
In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services.
The company provides its products in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas.
J. B.
Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.
| Country | India |
| Founded | 1976 |
| Industry | Pharmaceutical Preparations |
| Employees | 5,311 |
| CEO | Nikhil Chopra |
Contact Details
Address: Cnergy IT Park Mumbai, Maharashtra 400025 India | |
| Phone | 91 22 2439 5200 |
| Website | jbpharma.com |
Stock Details
| Ticker Symbol | 506943 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Nikhil Chopra | Chief Executive Officer |
| Narayan Saraf | Chief Financial Officer |
| Kunal Khanna | Chief Operating Officer |